CTS-QRHN joint webinar
The webinar was held on October 8, 2021 from 4:00 p.m. to 5:30 p.m.
Dre Andréanne Côté, Respirologist, MD, FRCPC
Quebec Heart and Lung institute, Laval University, Quebec, QC
Dr. Andréanne Côté is a pulmonary intensivist at the Quebec Heart and Lung Institute since 2018. She completed additional training at the University of Calgary in Alberta and a master's degree in clinical epidemiology at Laval University. She is a member of the Asthma Committee of the Canadian Thoracic Society. She also conducts research on asthma, particularly on the study of biomarkers for optimization of asthma treatment. She collaborated on the CTS Severe Asthma Position and the CHEST Cough Practice Guidelines.
Dre Connie Yang, Respirologist, MSc, MD, FRCPC, FAAP
Clinical Associate Professor, Director of the Asthma Clinic, Training Program Director, Division of Respiratory Medecine, University of British Columbia, Vancouver, BC
Dr. Connie Yang is a pediatric respirologist at BC Children’s Hospital in Vancouver where she is the director of the Pediatric Asthma Program. She is currently the co-chair of the CTS Asthma Assembly Steering Committee and led the development of the latest CTS Asthma Guideline on the Management of Very Mild and Mild Asthma. She is also the president of the Respiratory Health section of the Canadian Pediatric Society where she helps disseminate unified information on pediatric respiratory health topics.
Dr Mathieu Morissette, PhD
Associate Professor, Departement of Medecine, Laval University, Quebec Heart and Lung Institute, Quebec, QC
Dr Mathieu Morissette is an Associate Professor in the Department of Medicine at Université Laval and a researcher at the Quebec Heart and Lung Institute - UL in the Respiratory Health axis. He is the director of the Obstructive Lung Diseases and Remodeling axis at the Quebec Respiratory Health Network. His main research focuses are on the biology of lung damage and smoking as well as the pathobiology of COPD and emphysema. He also pursues research on the biology of vaping, trying to understand how this new habit affects the lungs and how it can interact with other environmental and microbial exposures to affect pulmonary health.
Dr Larry Lands, MD, PhD
Professor of Pediatrics, McGill University
Director, Pediatric Respiratory Medicine, McGill University Health Centre, Montreal, QC
Dr. Larry Lands is Director, Pediatric Respiratory Medicine and Director of the Pediatric Cystic Fibrosis (CF) Clinic at the McGill University Health Centre, an attending staff physician in the Quebec Lung Transplant Clinic, Centre Hospitalier d’Université de Montréal, and the respiratory consultant to the Pediatric Clinic and Adult and Pediatric CF Clinic, Centre Hospitalier de Rouyn-Noranda. He is a tenured Full Professor of Pediatrics at McGill University. He is Chair of the Canadian Thoracic Society Research Committee, Chair of CF Canada’s Research Advisory Council, and Co-chair of the protocol review subcommittee of CFCanACT. He chairs the Canadian Lung Association’s Studentship and Fellowship competitions and serves as a member of the Canadian Lung Association’s RENASCENT training program committee. His primary research interests are in inflammation and infection and functional capacity in patients with chronic lung disease, with a particular focus on CF and severe asthma.
- Acknowledge the changes in the assessment of asthmatic patients
- Review and comprehend the most recent changes in the CTS guidelines for the care of very mild to mild asthmatic patients
- Review the process of moving from evidence to recommendations
- Discuss gaps in current evidence for the management of very mild to mild asthma
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program (MOC) of The Royal College of Physicians and Surgeons of Canada and approved by the Canadian Thoracic Society. You may claim a maximum of 1.5 hour.
Statistics about participation
97 people attended this webinar